ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $14,000 | -65.0% | 10,459 | -53.8% | 0.00% | – |
| Q4 2021 | $40,000 | +60.0% | 22,622 | +93.4% | 0.00% | – |
| Q3 2021 | $25,000 | -41.9% | 11,698 | -4.3% | 0.00% | – |
| Q2 2021 | $43,000 | -63.6% | 12,228 | +2.3% | 0.00% | -100.0% |
| Q1 2021 | $118,000 | -16.3% | 11,953 | -8.1% | 0.00% | -20.0% |
| Q4 2020 | $141,000 | +9.3% | 13,006 | +3.9% | 0.01% | -16.7% |
| Q3 2020 | $129,000 | -43.4% | 12,518 | +14.5% | 0.01% | -45.5% |
| Q2 2020 | $228,000 | +117.1% | 10,932 | +1.8% | 0.01% | +266.7% |
| Q1 2020 | $105,000 | -10.3% | 10,738 | +5.5% | 0.00% | +50.0% |
| Q4 2019 | $117,000 | – | 10,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |